Spectrum Health General Surgery Residency, Grand Rapids, MI.
Spectrum Health Surgical Oncology, Grand Rapids, MI.
Surgery. 2023 Mar;173(3):633-639. doi: 10.1016/j.surg.2022.07.052. Epub 2022 Nov 12.
There is promising data on minimally invasive inguinal lymphadenectomy indicating decreased wound complications compared with the standard open approach. We examined our institutional experience with starting a minimally invasive inguinal lymphadenectomy program.
This is a retrospective case series of consecutive patients undergoing videoscopic minimally invasive inguinal lymphadenectomy from August 2017 to March 2022 by a single surgeon. Patients meeting criteria for inguinal lymphadenectomy were considered for minimally invasive inguinal lymphadenectomy unless there was skin involvement by tumor or bulky disease. Data collected included patient characteristics, primary cancer, surgery, and postoperative complications.
There were 26 patients included. The mean age was 60.6 ± 16.2 years. Most patients were female (n = 17, 65.4%), and the primary diagnosis was melanoma (n = 21, 19.2%). In 6 cases (23.1%), minimally invasive inguinal lymphadenectomy was combined with deep pelvic node dissection, but most patients did not have a concurrent procedure (n = 15, 57.7%). The median operative time was 119.0 minutes (range, 89.0-160.0), or 130.5 minutes (range, 89.0-345.0) when including concurrent procedures. The mean number of nodes retrieved was 9.8 ± 3.7, with a positive node identified in 19 patients (73.1%) during minimally invasive inguinal lymphadenectomy. There were 12 (46.2%) patients experiencing at least one postoperative complication within 30 days of surgery, the most common being infection (n = 4, 15.4%). One patient required reoperation for infected hematoma washout. Postoperative intervention for seroma was undertaken in 3 patients (11.5%).
Minimally invasive inguinal lymphadenectomy is a safe approach to inguinal lymph node dissection, in terms of node retrieval and postoperative complications, and can feasibly be adopted into practice with minimal learning curve.
微创腹股沟淋巴结清扫术的数据令人振奋,与标准的开放式手术相比,其减少了伤口并发症。我们检查了我们机构开展微创腹股沟淋巴结清扫术项目的经验。
这是一项回顾性病例系列研究,纳入了 2017 年 8 月至 2022 年 3 月期间由同一位外科医生进行的连续接受电视辅助微创腹股沟淋巴结清扫术的患者。符合腹股沟淋巴结清扫术标准的患者,除非肿瘤累及皮肤或疾病广泛,否则可考虑行微创腹股沟淋巴结清扫术。收集的数据包括患者特征、原发癌、手术和术后并发症。
共纳入 26 例患者。平均年龄为 60.6 ± 16.2 岁。大多数患者为女性(n=17,65.4%),原发诊断为黑色素瘤(n=21,19.2%)。在 6 例(23.1%)中,微创腹股沟淋巴结清扫术与深部盆腔淋巴结清扫术联合进行,但大多数患者没有同时进行其他手术(n=15,57.7%)。中位手术时间为 119.0 分钟(范围,89.0-160.0),包括同期手术时为 130.5 分钟(范围,89.0-345.0)。取出的平均淋巴结数量为 9.8 ± 3.7 个,微创腹股沟淋巴结清扫术中共发现 19 例(73.1%)阳性淋巴结。术后 30 天内至少有 12 例(46.2%)患者发生 1 种以上并发症,最常见的是感染(n=4,15.4%)。1 例患者因感染性血肿需再次手术冲洗。3 例(11.5%)患者行血清肿术后干预。
微创腹股沟淋巴结清扫术在淋巴结检出和术后并发症方面是一种安全的腹股沟淋巴结清扫术方法,并且可以在最小的学习曲线的情况下在实践中可行。